Telemedicine Digital-Native Businesses in Asia/Pacific and the Opportunities for IT Suppliers

Telemedicine Digital-Native Businesses in Asia/Pacific and the Opportunities for IT Suppliers

This IDC Market Perspective presents a high-level prediction and recommendations for technology vendors looking to supply telemedicine DNBs in the post-COVID-19 world. The COVID-19 pandemic accelerated the adoption of telemedicine by at least five years. However, as the pandemic restrictions begin to ease across the Asia/Pacific region, growth has slowed from pandemic-era peaks for telemedicine digital-native businesses (DNBs). However, telemedicine is still poised for double digit growth and is here to stay, offering ample opportunities for technology suppliers."COVID-19 restrictions made it difficult, even downright dangerous, to visit traditional healthcare providers. The need for an alternative to a conventional doctor's visit drove the growth of telemedicine, with users signing up in droves as the pandemic spread. However, with the world now looking toward the 'new normal' in the post-pandemic era, the growth of telemedicine has slowed from its previous peaks. Despite this fact, telemedicine DNBs are here to stay, and the challenges they face will still require the support of technology suppliers to overcome," said Seng Keong Low, research director, IDC Asia/Pacific.

Please Note: Extended description available upon request.